(BioEssays 2024 review et al., 2024: Review re-examining the claim that ivermectin turns Xenopus melanocytes into a metastatic melanoma-like state, finding inconsistencies with mammalian ivermectin studies and concluding the model is not suitable for testing melanoma therapeutics.
We conclude that while ivermectin may be a useful drug for many biomedical purposes, it is not ideal to induce a metastatic melanocyte phenotype in Xenopus for testing the effects of potential melanoma therapeutics.
n/a (HTML full text)
(BioEssays 2024 review et al., 2024: Review re-examining the claim that ivermectin turns Xenopus melanocytes into a metastatic melanoma-like state, finding inconsistencies with mammalian ivermectin studies and concluding the model is not suitable for testing melanoma therapeutics. Study type: narrative re-analysis/review of the Xenopus literature. N: n/a. Country: not established from the retrieved record. Dose: n/a. Funder/COI: not stated in the retrieved record. Comparator: n/a. Relevant because ivermectin's melanoma-related claims sometimes rest on the frog model; this paper says that model does not translate. Study type: review.
